NASDAQ:RCEL

Avita Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy RCEL

*Your capital is at risk

$4.16

-0.0300 (-0.716%)

At Close: Jun 03, 2026

AVITA Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.45M and sold 0 RCEL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	3.45M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 29, 2026 Buy	Common Stock A-Award	Vance Cary Guy President And CEO	CEO / President	5 000 Value: $15.3K
May 29, 2026 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	5 000 Value: $15.3K
May 20, 2026 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $9K
May 19, 2026 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $8K
Mar 11, 2026 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	1 800 Value: $9K
Feb 19, 2026 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	3 000 Value: $12.5K
Feb 18, 2026 Buy	Common Stock A-Award	Kelsey Nicole Chief Legal Officer	Officer	98 390 Value: $424.1K
Feb 18, 2026 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	105 470 Value: $454.6K
Feb 18, 2026 Buy	Stock Options (Right to Buy) A-Award	O'toole David D CFO	C-Suite Officer	155 510 Value: $670.2K
Feb 18, 2026 Buy	Stock Options (Right to Buy) A-Award	Kelsey Nicole Chief Legal Officer	Officer	145 060 Value: $625.2K
Jan 01, 2026 Buy	Common Stock J-Other	Woody Joseph Fralin Insider	Other	0 Value: $0
Aug 28, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	10 000 Value: $45.0K
Aug 28, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	10 000 Value: $45.0K
Aug 26, 2025 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $9K
Aug 26, 2025 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $9K
Aug 19, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	10 000 Value: $50.0K
Aug 19, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	10 000 Value: $50.0K
Aug 12, 2025 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $10K
Aug 12, 2025 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	2 000 Value: $10K
Aug 06, 2025 Buy	Common Stock J-Other	Tarnoff Michael E Insider	Other	0 Value: $0
Aug 06, 2025 Buy	Common Stock J-Other	Tarnoff Michael E Insider	Other	0 Value: $0
May 30, 2025 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	1 923 Value: $9K
May 30, 2025 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	1 923 Value: $9K
Mar 06, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	11 000 Value: $91.3K
Mar 06, 2025 Buy	Common Stock P-Purchase	Mcnamara Robert Director	Director	11 000 Value: $91.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AVITA MEDICAL, INC.

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a ...

Read Full Profile Here